FDA approves first ever vaccine for chikungunya virus, which is seeing a global surge

More than a quarter million cases of chikungunya virus have surfaced in South America this year. The virus can cause debilitating joint pain. Now the U.S. FDA has approved a new vaccine.

Related Keywords

Tanzania ,Buenos Aires ,Distrito Federal ,Argentina ,China ,Florida ,United States ,India ,Paraguay ,Texas ,Mozambique ,American ,America ,Peter Marks ,Susana Lloveras ,Nischay Mishra ,Margaret Kielian ,Peiqi Yin Department Of Cell Biology ,Drug Administration ,World Health Organization ,Columbia University School Of Public Health ,Albert Einstein College Of Medicine ,South American ,South America ,Columbia University School ,Albert Einstein College ,Peiqi Yin ,Cell Biology ,Nature Microbiology ,